Spermosens AB (publ) — Investor Relations & Filings

Spermosens AB is a company developing advanced diagnostic solutions for male-factor infertility. Its core product is the JUNO-CHECKED® system, a patented, automated diagnostic device based on a lab-on-chip platform. Unlike conventional methods that assess only the physical aspects of sperm, this technology evaluates their functional fertilization capacity by measuring their ability to bind to egg cell proteins. The system is designed to assist clinicians and embryologists in selecting the most appropriate Assisted Reproductive Technology (ART) treatment, specifically guiding the choice between standard In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI). By providing a more precise diagnosis for previously unexplained infertility cases, Spermosens aims to reduce the number of treatment cycles, increase efficiency, and improve outcomes for patients undergoing fertility treatments.